Skip to main content
OpenTrials

Clinical trial condition

DLBCL Transformed From Indolent Lymphoma

Explore clinical trials studying DLBCL Transformed From Indolent Lymphoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

DLBCL Transformed From Indolent Lymphoma trial results

Completed

Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant

NCT01321541

Conditions
DLBCL Transformed From Indolent Lymphoma, Diffuse Large B-cell Lymphoma, Disease Attributes, +17 more
Locations
  • Arizona Clinical Research Center Tucson, Arizona, United States
  • Arizona Oncology Associates Tucson, Arizona, United States
  • Highlands Oncology Group Bentonville, Arkansas, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
View all 131 locations
View Trial Details

Related conditions